SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Pneumococcal Carriage and Disease in Adults in England, 2011-2019: The Importance of Adults as a Reservoir for Pneumococcus in Communities.

El Safadi, D; Hitchins, L; Howard, A; Aley, P; Bowman, J; Bertran, M; Collins, A; Colin-Jones, R; Elterish, F; Fry, NK; et al. El Safadi, D; Hitchins, L; Howard, A; Aley, P; Bowman, J; Bertran, M; Collins, A; Colin-Jones, R; Elterish, F; Fry, NK; Gordon, SS; Gould, K; Hinds, J; Horn, E; Hyder-Wright, A; Kandasamy, R; Ladhani, S; Litt, D; Mitsi, E; Murphy, A; Pollard, AJ; Plested, E; Pojar, S; Ratcliffe, H; Robertson, MC; Robinson, H; Snape, MD; Solórzano, C; Voysey, M; Begier, E; Catusse, J; Lahuerta, M; Theilacker, C; Gessner, BD; Tiley, KS; Ferreira, DM (2025) Pneumococcal Carriage and Disease in Adults in England, 2011-2019: The Importance of Adults as a Reservoir for Pneumococcus in Communities. J Infect Dis, 231 (1). e17-e27. ISSN 1537-6613 https://doi.org/10.1093/infdis/jiae351
SGUL Authors: Hinds, Jason Gould, Katherine Ann

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (1MB) | Preview
[img] Archive (ZIP) (Supplementary data) Supplemental Material
Download (184kB)
[img]
Preview
PDF Accepted Version
Available under License Creative Commons Attribution.

Download (613kB) | Preview

Abstract

BACKGROUND: Pneumococcal carriage in healthy adults and its relationship to invasive pneumococcal disease (IPD) is not well understood. METHODS: Nasal wash samples from adults without close contact with young children (Liverpool, UK), 2011-2019, were cultured, and culture-negative samples tested by polymerase chain reaction (PCR). Pneumococcal carriage in adults 18-44 years was compared with carriage among pneumococcal conjugate vaccine-vaccinated children aged 13-48 months (nasopharyngeal swabs, Thames Valley, UK) and national IPD data, 2014-2019. Age group-specific serotype invasiveness was calculated and used with national IPD data to estimate carriage serotype distributions for ≥65 years. RESULTS: Overall, 98 isolates (97 carriers) were identified (3 solely by PCR) from 1631 ≥18 years adults (standardized carriage prevalence 6.4%). Despite different carriage and IPD serotype distributions between adults and children, serotype invasiveness was highly correlated (R = 0.9). Serotypes 3, 37, and 8 represented a higher proportion of adult carriage than expected. Predicted carriage serotype distributions for ≥65 years aligned closest with the young adult carriage serotype distribution. CONCLUSIONS: Nasal wash technique is highly sensitive. For some serotypes carried by adults aged ≥65 years, other adults may be an important reservoir for transmission. Age groups such as older children should also be considered.

Item Type: Article
Additional Information: © The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Keywords: adults, carriage, invasive pneumococcal disease, pneumococcal, transmission, Humans, Streptococcus pneumoniae, Pneumococcal Infections, Adult, Carrier State, England, Young Adult, Adolescent, Aged, Female, Male, Serogroup, Child, Preschool, Nasopharynx, Infant, Prevalence, Middle Aged, Pneumococcal Vaccines, Disease Reservoirs, pneumococcal, carriage, transmission, invasive pneumococcal disease, adults, adults, carriage, children, invasive pneumococcal disease, pneumococcal, transmission, 06 Biological Sciences, 11 Medical and Health Sciences, Microbiology
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title: J Infect Dis
ISSN: 1537-6613
Language: eng
Publisher License: Creative Commons: Attribution 4.0
Projects:
Project IDFunderFunder ID
UNSPECIFIEDPfizerhttp://dx.doi.org/10.13039/100004319
UNSPECIFIEDUniversity Of Oxfordhttp://dx.doi.org/10.13039/501100000769
UNSPECIFIEDNational Institute for Health and Care Researchhttps://doi.org/10.13039/501100000272
UNSPECIFIEDNIHR Oxford Biomedical Research Centrehttps://doi.org/10.13039/501100013373
UNSPECIFIEDNIHR Clinical Research Network Thames Valley and South Midlandshttps://doi.org/10.13039/501100012091
PubMed ID: 39013016
Web of Science ID: WOS:001278937400001
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/116698
Publisher's version: https://doi.org/10.1093/infdis/jiae351

Actions (login required)

Edit Item Edit Item